$CANF
Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares
XASE
Why is CANF up today? It is at $4.03 (+22.54%), and our scanner flagged it 18 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CANF spikes, and full due diligence on CANF — key stats, earnings, dilution and insider activity. Free.
Get free $CANF alerts the moment volume spikes
Our scanner flagged $CANF 18 times in the last 30 days. Create a free account to track $CANF, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $4.03
- Change today
- +22.54%
- Previous close
- $3.29
- 52-week range
- $2.56 – $13.40
- Market cap
- $7M
- Institutional own.
- 2.34%
- Total held
- 3.5%
- Tradeable float
- 2.1M 97% of shares · after 1% insiders + 2% institutions
- Short interest
- 62K ▼ -6% vs prior · as of 2026-08-14
- Short % of float
- 3.0%
- Days to cover
- 1.7d
- Avg daily volume
- 774K
- Exchange
- XASE
- 5mthin
- 4.7x
- 15mthin
- 5.3x
- 1hthin
- 5.4x
- 1D
- 403x
Get free CANF + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $CANF up today?
CANF is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 8 unusual-volume and momentum alerts on CANF today, peaking at 57.7x its normal volume. Fresh from the SEC: Can-Fite BioPharma Ltd. filed a Foreign issuer report (6-K). A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystForeign issuer report (6-K), from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Dilution watch
Active shelfRecent share offering + active shelf on file — the company raised capital and can raise more. If $CANF runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$CANF Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$CANF Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
CANF stock FAQ
Why is $CANF up today?
CANF is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 8 unusual-volume and momentum alerts on CANF today, peaking at 57.7x its normal volume. Fresh from the SEC: Can-Fite BioPharma Ltd. filed a Foreign issuer report (6-K). A material company disclosure like this is often the real catalyst behind a move of this size.
What is the CANF stock price today?
CANF last traded at $4.03, up 22.54% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live CANF alerts?
The CANF Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CANF 18 times in the last 30 days.
What exchange is CANF on?
CANF (Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares) trades on XASE, with a market cap of about $7M.
Is CANF good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CANF for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.